Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 28 for “"therapeutic protein"”.

  1. Genomic Analysis And Engineering Of Chinese Hamster Ovary Cells For Improved Therapeutic Protein Production

    Protein biologics have transformed the field of medicine in recent years. These complex molecules are produced in living cells, primarily Chinese Hamster Ovary (CHO) cells. Due to the importance of these therapeutic proteins to disease treatment, it is essential to improve the efficiency of their …

    umn Repository record for Genomic Analysis And Engineering Of Chinese Hamster Ovary Cells For Improved Therapeutic Protein Production (opens in a new tab)

  2. Rheology of concentrated protein solutions and attractive colloidal dispersions

    Therapeutic protein products with high solution concentration often possess extremely high viscosity and have difficulties in processing and delivery. It is desirable to predict and control the viscosity of protein solutions based on their interactions at the molecular level. Fundamental …

    mit Repository record for Rheology of concentrated protein solutions and attractive colloidal dispersions (opens in a new tab)

  3. Developing scalable and modular technologies for continuous biopharmaceutical production

    … cold-chains, the geographically biased nature of therapeutic protein production today can limit access to biologic drugs in developing areas of the world. These same logistical hurdles can also hamper the efficient distribution of life-saving protein therapeutics following crises in developed …

    mit Repository record for Developing scalable and modular technologies for continuous biopharmaceutical production (opens in a new tab)

  4. Development of preformed photo-crosslinked intravitreal implants for protein delivery to the posterior segment of the eye

    … the benefits of the introduction of commercial therapeutic protein products. The treatment of disorders of the back of the eye, which are collectively referred to as 'posterior segment diseases of the eye,' is made possible by this group of proteins. These disorders include age-related macular …

    qu-belfast Repository record for Development of preformed photo-crosslinked intravitreal implants for protein delivery to the posterior segment of the eye (opens in a new tab)

  5. Delipidation Treatments for Large-Scale Protein Purification Processing

    … insoluble. Lipid removal is desired prior to protein purification processing to decrease nonspecific fouling of downstream chromatographic matrices. Transgenic pig milk was used as a model system to study delipidation from therapeutic protein sources. The majority of triglycerides was …

    vt Repository record for Delipidation Treatments for Large-Scale Protein Purification Processing (opens in a new tab)

  6. Site-specific chemical and topological modifications to augment mRNA therapeutic potential

    Synthetic mRNA has emerged as a promising therapeutic platform for the treatment of a wide variety of diseases. Despite clinical demonstrations of mRNA for SARS-CoV-2 vaccines, mRNAs remain limited in application by their susceptibility to nucleases and overall short expression lifetime in vivo. We …

    mit Repository record for Site-specific chemical and topological modifications to augment mRNA therapeutic potential (opens in a new tab)

  7. The impact of variation in freezing and thawing process parameters on the critical quality attributes of a monoclonal antibody

    Therapeutic proteins or biopharmaceuticals have been playing an ever-increasing role in the treatment of human diseases over last 40 years. One of the main challenges with manufacture of these proteins is the stabilization of both the finished product and its processing intermediates during …

    cork Repository record for The impact of variation in freezing and thawing process parameters on the critical quality attributes of a monoclonal antibody (opens in a new tab)

  8. Engineering cell-based micropharmacies for in vivo protein replacement therapy

    … disorders depends on the consistent delivery of therapeutic proteins to correct underlying deficiencies or modulate disease progression. However, conventional methods, such as enzyme replacement therapy (ERT) and cancer immunotherapies, often require frequent infusions, suffer from limited tissue …

    umn Repository record for Engineering cell-based micropharmacies for in vivo protein replacement therapy (opens in a new tab)

  9. Cationic Polymers and Polymeric Micelles as Plasmid DNA and CRISPR-Cas9 Ribonucleoprotein Delivery Vehicles

    … and disorders worldwide and the traditional protein-based treatments are both expensive and require repetitive injections to maintain long-term effects. Gene therapy, as an alternative, holds great potential by direct delivery of genetic materials such as nucleic acids and genome editing …

    umn Repository record for Cationic Polymers and Polymeric Micelles as Plasmid DNA and CRISPR-Cas9 Ribonucleoprotein Delivery Vehicles (opens in a new tab)

  10. Polyelectrolyte multilayer growth factor delivery : mediating tissue/device interactions

    This thesis focuses on the use of ultrathin therapeutic protein delivery films to control host tissue/medical device implant interactions, thereby reducing complications that lead to implant failure. The Layer by Layer (LbL) deposition platform was used to fabricate conformal, tunable, micron scale …

    mit Repository record for Polyelectrolyte multilayer growth factor delivery : mediating tissue/device interactions (opens in a new tab)

  11. Feasibility of a predictive model of Hsp70b-activated gene therapy protein expression during ultrasound hyperthermia

    … system that can control when and where the therapeutic proteins will be generated. Our study was performed to determine the feasibility of attaching heat-inducible promoters to genes of interest in order to control activation of the gene in vivo via ultrasound-induced hyperthermia monitored …

    mit Repository record for Feasibility of a predictive model of Hsp70b-activated gene therapy protein expression during ultrasound hyperthermia (opens in a new tab)

  12. The Engineering of Chinese Hamster Ovary Cells to Achieve More Efficient Gene Amplification for Improving Biopharmaceutical Development

    … cells capable of producing high quantities of therapeutic proteins. It addresses the specific time bottlenecks associated with developing high producing CHO cell lines and reviews various methods that are employed to alleviate these bottlenecks. The specific time consuming process of gene …

    columbia-diss Repository record for The Engineering of Chinese Hamster Ovary Cells to Achieve More Efficient Gene Amplification for Improving Biopharmaceutical Development (opens in a new tab)

  13. Targeting the tight junction : immunotherapy of colon cancer

    A33 is a cell surface glycoprotein of colon epithelium with a long clinical history as a target in antibody-based cancer therapy. Despite being present in normal colon, radio-labeled antibodies against A33 are selectively retained by tumors at long time points. Accordingly, we have studied the …

    mit Repository record for Targeting the tight junction : immunotherapy of colon cancer (opens in a new tab)

  14. Evaluating future biopharmaceutical inspection needs, infrastructure capability gaps, and technology development strategies

    … properties of the manufactured drug product. As therapeutic protein formulations change from agonist to antagonist methods of action, the concentration of proteins in each dose increased by orders of magnitude, and with it, the challenge of producing and inspecting the product. Current inspection …

    mit Repository record for Evaluating future biopharmaceutical inspection needs, infrastructure capability gaps, and technology development strategies (opens in a new tab)

  15. Receptor Mediated Oral Delivery Of Bioencapsulated Green Fluorescent Protein Expressed In Transgenic Chloroplasts

    … expenses could be minimized or eliminated when therapeutic proteins are expressed and orally delivered via plant cells. Chloroplasts have the machinery to fold complex and biologically active eukaryotic proteins in the soluble chloroplast stromal compartment. Protein expression through …

    ucf

  16. Product and host engineering for low-cost manufacturing of therapeutic proteins in the yeast Komagataella phaffii

    … in low- and middle-income countries (LMICs). Therapeutic proteins, which can be stored as liquids, are more amenable to distribution in LMICs than newer modalities like therapeutic RNAs that require cryogenic storage. Currently, most therapeutic proteins are manufactured in either bacterial …

    mit Repository record for Product and host engineering for low-cost manufacturing of therapeutic proteins in the yeast Komagataella phaffii (opens in a new tab)

  17. Mass Spectrometry-Based Strategies for Biomolecular Structure Analysis: Steroid Metabolites Structures and Protein-Protein Interactions

    … small molecules and large biomolecules (e.g., proteins). The majority of the applications prior to 1970 were focused on small molecules, owing to the limited ionization methods which posed difficulties in producing gas-phase ions for large biomolecules then. Beginning in the 1980's, with the …

    wustl Repository record for Mass Spectrometry-Based Strategies for Biomolecular Structure Analysis: Steroid Metabolites Structures and Protein-Protein Interactions (opens in a new tab)

  18. Recombinant Engineering Strategies for the Production of Therapeutic Coagulation Factor Proteins

    … numerous blood dyscrasias and can be restored by therapeutic intervention with agents rich in coagulation factor proteins such as whole blood, fresh frozen plasma, prothrombin complex concentrates, and single coagulation factor concentrates. These agents are predominantly sourced from volunteer …

    umn Repository record for Recombinant Engineering Strategies for the Production of Therapeutic Coagulation Factor Proteins (opens in a new tab)

  19. Uniform biodegradable microparticle systems for protein delivery

    Therapeutic protein drugs are receiving increasing attention in pharmaceutical industry due to the fast development of biotechnology and genomics. Because of their low oral and transdermal bioavailabilities, fragility and short half-lives in vivo, novel and effective alternatives to deliver protein

    uiuc Repository record for Uniform biodegradable microparticle systems for protein delivery (opens in a new tab)

  20. Making In Utero Gene Therapy Safer and More Efficient: A First Step Towards Clinical Realization

    … the second delivery-vehicle, which carries the therapeutic protein and is packaged with the murine ecotropic envelope which restricts binding of the MR4IN vector to the mCAT-1 receptor, thus limiting its transduction to human or sheep cells that have been transduced by the first vector and …

    unr Repository record for Making In Utero Gene Therapy Safer and More Efficient: A First Step Towards Clinical Realization (opens in a new tab)

Page 1 of 2